Anavex Life Sciences Corp (AVXL)
9.035
+0.56
(+6.61%)
USD |
NASDAQ |
Nov 21, 16:00
9.035
0.00 (0.00%)
After-Hours: 17:08
Anavex Life Sciences Market Cap: 766.13M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 718.64M |
| November 19, 2024 | 698.71M |
| November 18, 2024 | 631.73M |
| November 15, 2024 | 631.30M |
| November 14, 2024 | 680.91M |
| November 13, 2024 | 753.83M |
| November 12, 2024 | 764.86M |
| November 11, 2024 | 775.88M |
| November 08, 2024 | 783.51M |
| November 07, 2024 | 647.41M |
| November 06, 2024 | 660.56M |
| November 05, 2024 | 652.93M |
| November 04, 2024 | 619.01M |
| November 01, 2024 | 579.58M |
| October 31, 2024 | 561.35M |
| October 30, 2024 | 484.18M |
| October 29, 2024 | 484.61M |
| October 28, 2024 | 490.12M |
| October 25, 2024 | 444.33M |
| October 24, 2024 | 451.96M |
| October 23, 2024 | 457.05M |
| October 22, 2024 | 478.25M |
| October 21, 2024 | 462.14M |
| October 18, 2024 | 479.09M |
| October 17, 2024 | 466.80M |
| Date | Value |
|---|---|
| October 16, 2024 | 468.50M |
| October 15, 2024 | 457.05M |
| October 14, 2024 | 458.74M |
| October 11, 2024 | 456.20M |
| October 10, 2024 | 433.30M |
| October 09, 2024 | 435.00M |
| October 08, 2024 | 444.33M |
| October 07, 2024 | 455.35M |
| October 04, 2024 | 474.43M |
| October 03, 2024 | 474.85M |
| October 02, 2024 | 479.52M |
| October 01, 2024 | 461.29M |
| September 30, 2024 | 481.64M |
| September 27, 2024 | 481.64M |
| September 26, 2024 | 480.79M |
| September 25, 2024 | 462.14M |
| September 24, 2024 | 471.46M |
| September 23, 2024 | 465.53M |
| September 20, 2024 | 478.25M |
| September 19, 2024 | 488.42M |
| September 18, 2024 | 466.38M |
| September 17, 2024 | 462.98M |
| September 16, 2024 | 483.33M |
| September 13, 2024 | 450.26M |
| September 12, 2024 | 441.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
121.62M
Minimum
Nov 22 2019
2.090B
Maximum
Jun 28 2021
672.43M
Average
651.94M
Median
Jul 03 2023
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
| Oragenics Inc | 3.301M |
Market Cap Related Metrics
| Price to Book Value | 5.903 |
| Price | 9.035 |
| Earnings Yield | -5.64% |